Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
29.20
+1.16 (4.14%)
At close: Nov 3, 2026, 4:00 PM EST
29.20
0.00 (0.00%)
After-hours: Nov 3, 2026, 5:03 PM EST
Amylyx Pharmaceuticals Market Cap
Amylyx Pharmaceuticals has a market cap or net worth of $3.66 billion as of November 3, 2026. It is the 4,562nd most valuable company in the world and the 1,398th biggest in the United States. Its market cap has increased by 146.65% in one year.
Market Cap
3.66B
Enterprise Value
3.42B
1-Year Change
146.65%
Global Rank
Country Rank
#1,398 United States
Category
ChartMarket Cap Chart
Since the IPO on January 7, 2022, Amylyx Pharmaceuticals's market cap has increased from $1.07B to $3.66B, an increase of 242.78%. That is a compound annual growth rate of 29.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 3.66B | 176.26% |
| Dec 31, 2025 | 1.33B | 415.49% |
| Dec 31, 2024 | 257.35M | -74.11% |
| Dec 29, 2023 | 993.86M | -59.40% |
| Dec 30, 2022 | 2.45B | 128.97% |
| Jan 7, 2022 | 1.07B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hims & Hers Health | 6.25B |
| Indivior Pharmaceuticals | 4.30B |
| Liquidia | 3.84B |
| Regencell Bioscience Holdings | 3.20B |
| Bausch Health Companies | 3.05B |
| Supernus Pharmaceuticals | 2.44B |
| Prestige Consumer Healthcare | 2.35B |
| HUTCHMED (China) | 2.34B |